Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated:  9/26/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated: 9/26/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated:  9/26/2015
Christiana Care Health Services, Inc
mi
from
Newark, DE
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated: 9/26/2015
Christiana Care Health Services, Inc
mi
from
Newark, DE
Click here to add this to my saved trials
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated:  9/26/2015
University of Miami
mi
from
Miami, FL
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated: 9/26/2015
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated:  9/26/2015
University of Maryland, Baltimore
mi
from
Baltimore, MD
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated: 9/26/2015
University of Maryland, Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated:  9/26/2015
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated: 9/26/2015
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated:  9/26/2015
Baltimore VA
mi
from
Baltimore, MD
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated: 9/26/2015
Baltimore VA
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated:  9/26/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated: 9/26/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated:  9/26/2015
St. Patrick Hospital and Health Science Center
mi
from
Missoula, MT
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated: 9/26/2015
St. Patrick Hospital and Health Science Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated:  9/26/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated: 9/26/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated:  9/26/2015
University of Oklahoma
mi
from
Oklahoma City, OK
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated: 9/26/2015
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated:  9/26/2015
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated: 9/26/2015
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated:  9/26/2015
University of Texas, San Antonio
mi
from
San Antonio, TX
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
Randomized, Multi-Center, Comparative Trial of Short-Course Empiric Antibiotic Therapy Versus Standard Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the Intensive Care Unit (ICU)
Status: Enrolling
Updated: 9/26/2015
University of Texas, San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, MD: A Pilot Study of Biomarkers
Status: Enrolling
Updated:  9/26/2015
Johns Hopkins University
mi
from
Baltimore, MD
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, MD: A Pilot Study of Biomarkers
Status: Enrolling
Updated: 9/26/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Being Responsible for Ourselves HIV Risk Reduction for Black MSM
Help Us, Save Us! HIV/STI Risk Reduction for Black Men Who Have Sex With Men
Status: Enrolling
Updated:  9/28/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Being Responsible for Ourselves HIV Risk Reduction for Black MSM
Help Us, Save Us! HIV/STI Risk Reduction for Black Men Who Have Sex With Men
Status: Enrolling
Updated: 9/28/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women Aged 18 to 40 Years.
Status: Enrolling
Updated:  9/29/2015
305, Northern California CRC
mi
from
Redding, CA
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women Aged 18 to 40 Years.
Status: Enrolling
Updated: 9/29/2015
305, Northern California CRC
mi
from
Redding, CA
Click here to add this to my saved trials
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women Aged 18 to 40 Years.
Status: Enrolling
Updated:  9/29/2015
301, Johnson County Clin-Trials
mi
from
Lenexa, KA
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women Aged 18 to 40 Years.
Status: Enrolling
Updated: 9/29/2015
301, Johnson County Clin-Trials
mi
from
Lenexa, KA
Click here to add this to my saved trials
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women Aged 18 to 40 Years.
Status: Enrolling
Updated:  9/29/2015
304, SNBL Clinical Pharmacaolofy Center, Inc.
mi
from
Baltimore, MD
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women Aged 18 to 40 Years.
Status: Enrolling
Updated: 9/29/2015
304, SNBL Clinical Pharmacaolofy Center, Inc.
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women Aged 18 to 40 Years.
Status: Enrolling
Updated:  9/29/2015
302, Southwestern Medical Clinic PC
mi
from
Stevensville, MT
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women Aged 18 to 40 Years.
Status: Enrolling
Updated: 9/29/2015
302, Southwestern Medical Clinic PC
mi
from
Stevensville, MT
Click here to add this to my saved trials
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women Aged 18 to 40 Years.
Status: Enrolling
Updated:  9/29/2015
303, USA Foothill Family Clinic North Salt Lake City UT
mi
from
Salt Lake City, UT
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women Aged 18 to 40 Years.
Status: Enrolling
Updated: 9/29/2015
303, USA Foothill Family Clinic North Salt Lake City UT
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women Aged 18 to 40 Years.
Status: Enrolling
Updated:  9/29/2015
102, CEV University of Antwerp
mi
from
Antwerp,
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women Aged 18 to 40 Years.
Status: Enrolling
Updated: 9/29/2015
102, CEV University of Antwerp
mi
from
Antwerp,
Click here to add this to my saved trials
Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector Vaccine
Transcutaneous Immunization With actA/plcB-Deleted Listeria Monocytogenes Expressing Influenza A Nucleoprotein (BMB72) and Cholera Toxin Adjuvant
Status: Enrolling
Updated:  9/30/2015
Massachusetts General Hospital
mi
from
Boston, MA
Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector Vaccine
Transcutaneous Immunization With actA/plcB-Deleted Listeria Monocytogenes Expressing Influenza A Nucleoprotein (BMB72) and Cholera Toxin Adjuvant
Status: Enrolling
Updated: 9/30/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children
Innate Immunity and RSV Infection in Children
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin-Madison
mi
from
Madison, WI
Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children
Innate Immunity and RSV Infection in Children
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE)
A Pilot Randomized Trial to Determine the Efficacy of a Probiotic, Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin Hospital
mi
from
Madison, WI
A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE)
A Pilot Randomized Trial to Determine the Efficacy of a Probiotic, Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA)
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin Hospital
mi
from
Madison, WI
Click here to add this to my saved trials
Vaccine for Recurrent Urinary Tract Infections in Women
Phase 2 Clinical Trial of Vaginal Mucosal Immunization for Recurrent Urinary Tract Infections
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Vaccine for Recurrent Urinary Tract Infections in Women
Phase 2 Clinical Trial of Vaginal Mucosal Immunization for Recurrent Urinary Tract Infections
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Sexually Transmitted Infections Among African American Women Who Have Sex With Women
Sexually Transmitted Infections Among African American Women Who Have Sex With Women
Status: Enrolling
Updated:  10/2/2015
Jefferson County Health Department
mi
from
Birmingham, AL
Sexually Transmitted Infections Among African American Women Who Have Sex With Women
Sexually Transmitted Infections Among African American Women Who Have Sex With Women
Status: Enrolling
Updated: 10/2/2015
Jefferson County Health Department
mi
from
Birmingham, AL
Click here to add this to my saved trials
Sexually Transmitted Infections Among African American Women Who Have Sex With Women
Sexually Transmitted Infections Among African American Women Who Have Sex With Women
Status: Enrolling
Updated:  10/2/2015
UAB Personal Health Clinic
mi
from
Birmingham, AL
Sexually Transmitted Infections Among African American Women Who Have Sex With Women
Sexually Transmitted Infections Among African American Women Who Have Sex With Women
Status: Enrolling
Updated: 10/2/2015
UAB Personal Health Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Case Control Study of Women With Multiple Sexual Partners
A Case Control Study of Women With Multiple Sexual Partners Attending the Jefferson County Department of Health Sexually Transmitted Diseases Clinic
Status: Enrolling
Updated:  10/2/2015
Jefferson County Department of Health
mi
from
Birmingham, AL
A Case Control Study of Women With Multiple Sexual Partners
A Case Control Study of Women With Multiple Sexual Partners Attending the Jefferson County Department of Health Sexually Transmitted Diseases Clinic
Status: Enrolling
Updated: 10/2/2015
Jefferson County Department of Health
mi
from
Birmingham, AL
Click here to add this to my saved trials
HLA-Identical Sibling Renal Transplant Tolerance
HLA-Identical Sibling Renal Transplant Tolerance With Donor Hematopoietic Stem Cells and Campath-1H
Status: Enrolling
Updated:  10/5/2015
Northwestern Memorial Hospital
mi
from
Chicago, IL
HLA-Identical Sibling Renal Transplant Tolerance
HLA-Identical Sibling Renal Transplant Tolerance With Donor Hematopoietic Stem Cells and Campath-1H
Status: Enrolling
Updated: 10/5/2015
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated:  10/5/2015
UCLA, Center for Clinical AIDS Research and Education
mi
from
Los Angeles, CA
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated: 10/5/2015
UCLA, Center for Clinical AIDS Research and Education
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated:  10/5/2015
Albert Einstein College of Medicine
mi
from
Bronx, NY
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated: 10/5/2015
Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated:  10/5/2015
Montefiore Medical Center - Moses Campus
mi
from
Bronx, NY
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated: 10/5/2015
Montefiore Medical Center - Moses Campus
mi
from
Bronx, NY
Click here to add this to my saved trials
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated:  10/5/2015
Montefiore Medical Center-Einstein Campus
mi
from
Bronx, NY
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated: 10/5/2015
Montefiore Medical Center-Einstein Campus
mi
from
Bronx, NY
Click here to add this to my saved trials
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated:  10/5/2015
University of California, San Diego
mi
from
San Diego, CA
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection
A Phase I/Pharmacokinetic Study of Erlotinib for Advanced Non-small Cell Lung Cancer in Persons With HIV Infection
Status: Enrolling
Updated: 10/5/2015
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Reducing Inappropriate Antibiotic Prescribing by Primary Care Clinicians
Reducing Inappropriate Antibiotic Prescribing by Primary Care Clinicians
Status: Enrolling
Updated:  10/5/2015
Denver Health and Hospitals Authority
mi
from
Denver, CO
Reducing Inappropriate Antibiotic Prescribing by Primary Care Clinicians
Reducing Inappropriate Antibiotic Prescribing by Primary Care Clinicians
Status: Enrolling
Updated: 10/5/2015
Denver Health and Hospitals Authority
mi
from
Denver, CO
Click here to add this to my saved trials
Treatment of Hemodialysis Catheter-Related Bacteremia
RCT for the Treatment of Hemodialysis Catheter-Related Bacteremia
Status: Enrolling
Updated:  10/6/2015
University of California San Diego Medical Center
mi
from
San Diego, CA
Treatment of Hemodialysis Catheter-Related Bacteremia
RCT for the Treatment of Hemodialysis Catheter-Related Bacteremia
Status: Enrolling
Updated: 10/6/2015
University of California San Diego Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Stage Matched Intervention to Increase Dual Method Use
Stage Matched Intervention to Increase Dual Method Use
Status: Enrolling
Updated:  10/6/2015
Women and Infants Hospital
mi
from
Providence, RI
Stage Matched Intervention to Increase Dual Method Use
Stage Matched Intervention to Increase Dual Method Use
Status: Enrolling
Updated: 10/6/2015
Women and Infants Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Status: Enrolling
Updated:  10/7/2015
Ann & Robert H. Lurie Children's Hospital of Chicago (LCH) CRS
mi
from
Chicago, IL
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Status: Enrolling
Updated: 10/7/2015
Ann & Robert H. Lurie Children's Hospital of Chicago (LCH) CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Status: Enrolling
Updated:  10/7/2015
Johns Hopkins University Center for Immunization Research
mi
from
Baltimore, MD
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Status: Enrolling
Updated: 10/7/2015
Johns Hopkins University Center for Immunization Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Status: Enrolling
Updated:  10/7/2015
Rush Univ. Cook County Hosp. Chicago NICHD CRS
mi
from
Chicago, IL
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Status: Enrolling
Updated: 10/7/2015
Rush Univ. Cook County Hosp. Chicago NICHD CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Status: Enrolling
Updated:  10/7/2015
St. Jude Children's Research Hospital CRS
mi
from
Memphis, TN
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Status: Enrolling
Updated: 10/7/2015
St. Jude Children's Research Hospital CRS
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Status: Enrolling
Updated:  10/7/2015
Univ. of Colorado Denver NICHD CRS
mi
from
Aurora, CO
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Status: Enrolling
Updated: 10/7/2015
Univ. of Colorado Denver NICHD CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Status: Enrolling
Updated:  10/7/2015
University of California, UC San Diego CRS
mi
from
La Jolla, CA
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Status: Enrolling
Updated: 10/7/2015
University of California, UC San Diego CRS
mi
from
La Jolla, CA
Click here to add this to my saved trials
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Status: Enrolling
Updated:  10/7/2015
Usc La Nichd Crs
mi
from
Alhambra, CA
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID ΔM2-2 in RSV-Seronegative Infants and Children
Status: Enrolling
Updated: 10/7/2015
Usc La Nichd Crs
mi
from
Alhambra, CA
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated:  10/8/2015
Clinical Research Facility
mi
from
Costa Mesa, CA
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated: 10/8/2015
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated:  10/8/2015
Clinical Research Facility
mi
from
DeLand, FL
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated: 10/8/2015
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated:  10/8/2015
Clinical Research Facility
mi
from
Orlando, FL
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated: 10/8/2015
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated:  10/8/2015
Clinical Research Facility
mi
from
Kansas City, MO
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated: 10/8/2015
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated:  10/8/2015
Clinical Research Facility
mi
from
Saint Louis, MO
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated: 10/8/2015
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated:  10/8/2015
Clinical Research Facility
mi
from
Berlin, NJ
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated: 10/8/2015
Clinical Research Facility
mi
from
Berlin, NJ
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated:  10/8/2015
Clinical Research Facility
mi
from
Marlton, NJ
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated: 10/8/2015
Clinical Research Facility
mi
from
Marlton, NJ
Click here to add this to my saved trials